Anuj Vermani0:26
Good evening everyone. Dr. Mukesh Ayyangar, President and CEO, USISPF; Mr. John Chambers, Chairman, USISPF, and Founder and CEO of JC2 Ventures; Michael Miebach, Chief Executive Officer, MasterCard; Mr. Frank St. John, CEO of Lockheed Martin; Ms. Menaka Doshi, Senior Editor, Bloomberg India; distinguished industry leaders, delegates, and representatives from the media. It is my honor today to deliver the scene-setting remarks for this inaugural discussion on strengthening bilateral trade ties: opportunities and challenges. The relationship between India and the United States has evolved significantly over the past decade, transitioning from a cautious partnership to a robust and dynamic friendship. This transformation has been driven by strategic interests, common goals, and a shared vision for global prosperity and stability. Important bilateral and multilateral engagements that the two countries are participating in include IPEF, Quad, the recently concluded Commercial Dialogue, and the Trade Policy Forum. These are all helping lay the foundation for strengthening global value chains and enhancing the partnership between the two countries for economic prosperity and security. There are several exemplary partnerships that American and Indian companies have formed in a number of industries, including in the healthcare space, leveraging our collective strengths. Reconfiguration of global value chain supply presents one of the most significant opportunities, especially as COVID-19 exposed vulnerabilities in production strategies and supply chains across the world. Today, the industry is linking their value chains globally across a range of activities from innovation, manufacturing, marketing, education, and distribution, and the US-India partnership provides a strong foundation to leverage and maximize this advantage. Now, India has a stated goal of $2 trillion in exports by 2030, and accordingly, our government has recognized the need to diversify its export base and further deepen participation in global supply chains and value chains. To achieve this, our government has played a key role through macroeconomic policies, through infrastructure building, enabling a regulatory environment that's conducive to this, and human capital development. All robust policies such as the PLI scheme, a focus on ease of doing business, have all boosted investor confidence, while at the same time there are areas that continue to be opportunities to further the potential. The Trade Policy Forum and other bilateral discussions have led to some very encouraging and positive policy developments. Industry was heartened by the statement that emerged from the TPF meeting that was held between Minister Goyal and the USTR representative Ambassador Katherine Tai earlier this year, where both sides have committed to work and further resolve several bilateral trade and investment barriers, including the areas of intellectual property, market access, cooperation on digital trade and technologies, data laws, customs and facilitation, regulatory harmonization, QoS standards, pricing for medical devices, and many, many other initiatives. We have also seen very strong progress in areas such as intellectual property with the patent amendment rules and positive steps towards regulatory harmonization with India recently announcing the decision to join the IMDRF. We remain very positive and very hopeful of further dialogue on these topics, which will continue to boost investor confidence. Further, in closing, Johnson & Johnson has had the privilege of serving India's healthcare needs since independence, since 1947. We feel extremely proud of the legacy of innovation, skilling, access, and partnership we have in India, an impact for patients and augmenting growth of the Indian economy. As one of the world's leading healthcare companies, we advocate for policy measures that support strong, resilient global value chains that help and ensure that patients, providers, consumers all have access to medical goods, including during major public health crises. We remain committed to working together with several partners, including central and state governments, to continue to bring the best of Johnson & Johnson innovation and services to the nation. With this, I hand over to you, Ms. Doshi.